Search

Your search keyword '"Roobol, Monique J."' showing total 1,922 results

Search Constraints

Start Over You searched for: Author "Roobol, Monique J." Remove constraint Author: "Roobol, Monique J."
1,922 results on '"Roobol, Monique J."'

Search Results

103. How to follow the new EU Council recommendation and improve prostate cancer early detection: the Prostaforum 2022 declaration

104. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

106. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

107. External validation of the Rotterdam Prostate Cancer Risk Calculator within a Dutch high-risk clinical cohort

110. Supplementary Materials and Methods from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

111. Supplementary Figure Legends from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

112. Supplementary Tables 1 through 8 and Supplementary Figures 1 through 15 from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

113. Data from A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

114. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer : a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

115. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men

116. Navigating through the Controversies and Emerging Paradigms in Early Detection of Prostate Cancer:Bridging the Gap from Classic RCTs to Modern Population-Based Pilot Programs

117. Lymphoceles after pelvic lymph node dissection during robot-assisted radical prostatectomy

118. A literature review to understand health literacy in men with prostate cancer on active surveillance

119. How to follow the new EU Council recommendation and improve prostate cancer early detection:the Prostaforum 2022 declaration

120. Active Surveillance for Prostate Cancer:Past, Current, and Future Trends

121. Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death:Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

122. A Detailed Evaluation of the Effect of Prostate-specific Antigen–based Screening on Morbidity and Mortality of Prostate Cancer:21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer

123. The Patient Journey from Randomization to Detection of Prostate Cancer and Death:Results from ERSPC Rotterdam

124. Prostate cancer risk assessment by the primary care physician and urologist:transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator

125. Mapping European Association of Urology Guideline Practice Across Europe:An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

126. Shifting risk-stratified early prostate cancer detection to a primary healthcare setting

127. Interaction of MRI and active surveillance in prostate cancer:Time to re-evaluate the active surveillance inclusion criteria

128. Research protocol to identify progression and death amongst patients with metastatic hormone-sensitive prostate cancer treated with available treatments: PIONEER IMI's 'big data for better outcomes' program

129. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries

132. Evaluating Approaches for Constructing Polygenic Risk Scores for Prostate Cancer in Men of African and European Ancestry

133. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

135. Publisher Correction: Shared heritability and functional enrichment across six solid cancers

136. Shared heritability and functional enrichment across six solid cancers

137. Prostate cancer risk assessment by the primary care physician and urologist: transabdominal- versus transrectal ultrasound prostate volume-based use of the Rotterdam Prostate Cancer Risk Calculator

138. The combined role of MRI prostate and prostate health index in improving detection of significant prostate cancer in a screening population of Chinese men

139. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

146. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

149. External validation of the Rotterdam prostate cancer risk calculator within a high-risk Dutch clinical cohort

150. Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection

Catalog

Books, media, physical & digital resources